
Novadip Biosciences SA raises €40m
Belgian regenerative medicine specialist Novadip Biosciences has raised €40m to push clinical development of its two investigational adipose stem...

Germany’s Curevac offers common shares
In addition to these ordinary shares, Tübingen-based CureVac is enticing investors to give up another 15% of the number of ordinary shares under the...

CatalYm GmbH raises €50m to push visugromab development
Following a €60m Series B financing in 2020, Martinsried-based CatalYm GmbH announced the closing of a Series C financing round of €50m. The...

New polymer can stop biofilm formation
The acrylate co-polymer reported by Jean-Frédéric Dubern and colleagues in Science Advances (doi: 10.1126/sciadv.add7474) have the potential to...

Amgen wins race of top `22 deals with $26bn for Horizon thx
Horizon confirmed Amgen's interest in a press release. The American group is to offer around $116.5 for each share. The offer price is about 20...

Memo Therapeutics and Ono Pharmaceutical enter partnership
Under the terms of the agreement, Memo Therapeutics AG will leverage its microfluidic single-cell molecular cloning and screening technologies to...

European Commission calls for reversal of Illumina's $7bn Grail merger
The commission on Monday sent a "statement of objections" outlining the process Illumina must follow in divesting Grail, its blood-testing...